Allspring Global Investments
VRTX icon

Allspring Global Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Allspring Global Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.4M Buy
123,760
+1,550
+1% +$723K 0.09% 258
2025
Q4 		$55.3M Sell
122,210
-4,653
-4% -$2.01M 0.09% 257
2025
Q3 		$51.3M Buy
126,863
+323
+0.3% +$135K 0.08% 282
2025
Q2 		$57.2M Buy
126,540
+18,011
+17% +$8.3M 0.1% 256
2025
Q1 		$52.6M Buy
108,529
+11,903
+12% +$5.55M 0.09% 275
2024
Q4 		$39.2M Sell
96,626
-139,700
-59% -$64.8M 0.06% 356
2024
Q3 		$110M Buy
236,326
+37,399
+19% +$18M 0.17% 138
2024
Q2 		$93.2M Sell
198,927
-32,529
-14% -$14.1M 0.15% 155
2024
Q1 		$96.8M Buy
231,456
+18,113
+8% +$7.66M 0.15% 158
2023
Q4 		$86.8M Sell
213,343
-27,711
-11% -$10.2M 0.14% 169
2023
Q3 		$83.8M Sell
241,054
-156,611
-39% -$54.8M 0.15% 167
2023
Q2 		$140M Sell
397,665
-9,598
-2% -$3.23M 0.22% 104
2023
Q1 		$128M Sell
407,263
-45,307
-10% -$13.6M 0.21% 107
2022
Q4 		$131M Sell
452,570
-24,631
-5% -$7.51M 0.22% 108
2022
Q3 		$138M Buy
477,201
+95,856
+25% +$27.6M 0.24% 89
2022
Q2 		$107M Buy
381,345
+68,586
+22% +$18.4M 0.18% 148
2022
Q1 		$81.6M Sell
312,759
-22,846
-7% -$5.42M 0.1% 263
2021
Q4 		$73.7M Buy
+335,605
New +$65.3M 0.08% 313

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Allspring Global Investments's VRTX Position: Q1 2026 in Review

Allspring Global Investments increased its Vertex Pharmaceuticals (VRTX) stake by 1.3% in Q1 2026, buying an estimated $723K and bringing the position to 123,760 shares worth $55.4M. The position accounts for 0.09% of the portfolio, ranked #258.

Allspring Global Investments first reported a position in VRTX in Q4 2021 and has held it in 18 quarters since. The position peaked at $140M in Q2 2023. 1,692 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Allspring Global Investments held 123,760 shares of Vertex Pharmaceuticals worth $55.4M as of Q1 2026.
  • Allspring Global Investments bought 1,550 Vertex Pharmaceuticals shares in Q1 2026, an estimated $723K.
  • Vertex Pharmaceuticals made up 0.09% of Allspring Global Investments's portfolio in Q1 2026, its #258 holding.
  • Allspring Global Investments first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's Vertex Pharmaceuticals position peaked at $140M in Q2 2023.
  • 1,692 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.